Literature DB >> 7798412

CO2, argon, and pulsed dye laser treatment of angiofibromas.

P Boixeda1, E Sánchez-Miralles, J M Azaña, J M Arrazola, R Moreno, A Ledo.   

Abstract

BACKGROUND: Tuberous sclerosis is a complex disorder of hamartoma formation in many organs, particularly the skin, brain, eye, kidney, and heart. The characteristic skin lesions are angiofibromas (AF), the shagreen patch, periungual fibromas, and "ash-leaf" white macules. Treatment for AF has previously included electrocoagulation, electrodesiccation and curettage, dermabrasion, excision, cryosurgery, and oral 13-cis retinoic acid. Both argon and CO2 lasers have been used in isolated cases to treat AF.
OBJECTIVE: The purpose of this work is the study of the application of three different lasers in the treatment of facial AF.
METHODS: Ten patients with facial AF were treated with CO2, argon, and pulsed dye lasers. Patients' AF were graded with regard to the size and color of the lesions. A 2-3-cm2 test was assayed on the face of all patients with each laser before performing a complete treatment and in order to choose the best laser.
RESULTS: Results were considered excellent in seven patients and good in three patients, with decrease of erythema and flattening of the AF. Minimal scarring was noted in two patients. Transient erythema was observed in patients treated with the CO2 laser. All patients or their parents considered the treatment cosmetically satisfactory.
CONCLUSION: We found the CO2 laser to be a better therapeutic tool than the argon laser to treat AF, especially in those patients with multiple and protuberant AF. The argon laser would be more useful in those patients with very red AF and light complexion, and the pulsed dye laser in those with very red and flat AF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798412     DOI: 10.1111/j.1524-4725.1994.tb03709.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  4 in total

Review 1.  [Medical dermatologic laser therapy. A review].

Authors:  B Greve; C Raulin
Journal:  Hautarzt       Date:  2003-05-23       Impact factor: 0.751

Review 2.  mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology.

Authors:  Anna Jeong; Michael Wong
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

Review 3.  Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role.

Authors:  Michael A Cardis; Cynthia Marie Carver DeKlotz
Journal:  Arch Dis Child       Date:  2017-03-28       Impact factor: 3.791

4.  Large nipple areolar complex angiofibroma treated with combined surgical debulking and carbon dioxide laser therapy - a case report.

Authors:  Karen B Lu; Anamaria Parus; Ashley Siegel; Candace Glenn; David M Plank
Journal:  Case Reports Plast Surg Hand Surg       Date:  2020-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.